FIELD: technological processes.
SUBSTANCE: present invention relates to a method of determining cefotaxime by reversed-phase high-performance liquid chromatography, comprising an isocratic mode of elution using a chromatographic column filled with a sorbent with particle size of 5 mcm, used as a mobile phase is a mixture of a solution of ammonium acetate with acetonitrile, characterized by the fact that chromatographic separation is carried out on a column with size of 250×3 mm, filled with sorbent C18, using as a mobile phase mixture of 0.02 M ammonium acetate solution pH = 4.7 with acetonitrile in ratio of 90:10 using ultraviolet detector at wave length 252 nm and volume of introduced sample 10 mcl.
EFFECT: effective separation of cefotaxime with impurity compounds of the sample and providing high retention of cefotaxime, which increases sensitivity and resolution of the method, reduced consumption of the mobile phase, which increases cost-effectiveness of analysis.
1 cl, 2 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINATION OF AMINOGLYCOSIDE ANTIBIOTICS BY REVERSE-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY | 2022 |
|
RU2786839C1 |
METHOD FOR DETERMINATION OF CIPROFLOXACIN BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY | 2020 |
|
RU2751338C1 |
METHOD FOR DETERMINING THE RELEASE RATE OF CEFOTAXIME ENCAPSULATED IN NIOSOMES IN VITRO | 2020 |
|
RU2754850C1 |
METHOD FOR DETERMINING AMIODARONE AND ITS MAIN METABOLITE DESETHYLAMIODARONE IN HUMAN BLOOD SERUM | 2020 |
|
RU2749566C1 |
METHOD FOR THE QUANTITATIVE DETERMINATION OF DEXPANTHENOL AND CHITOSAN IN THEIR JOINT PRESENCE IN A GEL | 2021 |
|
RU2760525C1 |
METHOD OF DETERMINING CONTENT OF OESTROGEN AND DEXPANTHENOL IN TWO-COMPONENT MEDICAL DRUG BY HPLC | 2011 |
|
RU2476873C1 |
METHOD FOR EXTENSION OF SORBENT SERVICE LIFE IN INDUSTRIAL PURIFICATION OF GENETICALLY ENGINEERED INSULIN HUMAN | 2008 |
|
RU2383624C2 |
METHOD OF PURIFYING TRIPTORELIN | 2015 |
|
RU2585105C1 |
METHOD OF DETERMINING CONTENT OF HYDROXYMETHYL QUINOXYLINE DIOXIDE AND IMPURITIES THEREOF BY HPLC | 2012 |
|
RU2517761C1 |
METHOD OF DETERMINING CONTENT OF TROXERUTIN, DEXPANTHENOL, BENZOCAINE AND METHYL PARAHYDROXYBENZOATE IN MEDICAL DRUG BY HPLC | 2011 |
|
RU2475733C1 |
Authors
Dates
2019-05-14—Published
2018-10-08—Filed